Replies to post #98427 on Biotech Values

[mcbio]

Re: IDX184 Phase 1b results

Do you recall the sequence of events with IDX184? Some of the clueless Wall Street analysts panned the phase-1b results and then had to reverse themselves and praise the compound when IDIX released the 14-day data from phase-2a.

Yes, that was a bit of a mess. On the bright side, the confusion afforded us IDIX longs a nice opportunity to pick up some shares on the cheap. However, I don't want to repeat that fiasco with IDX320 as I'm a bit short on funds. ; ) I imagine that scenario is less likely with IDX320 though since it's a PI whereas IDX184 is a nuke. (I think PIs tend to show their potency more quickly than the nukes, right?)